Entering text into the input field will update the search result below

Candel Therapeutics signs $25M non-dilutive debt financing agreement with Silicon Valley Bank

  • Candel Therapeutics (NASDAQ:CADL) entered into a loan and security agreement with Silicon Valley Bank for $25M, $20M of which will be available immediately; additional $5M will be available in the future if certain conditions and milestones are met.
  • The loan agreement

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About CADL

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Candel Therapeutics, Inc.
Synlogic, Inc.
Molecular Templates, Inc.
Xilio Therapeutics, Inc.
Cardio Diagnostics Holdings, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.